Streetbeat News

Equity Actions

VBIV

VBI Vaccines Inc has expanded its hepatitis B partnership with Brii Biosciences. Brii Bio has acquired a worldwide exclusive license for VBI-2601 and an exclusive license for PreHevbri in the Asia Pacific region from VBI. Brii Bio will pay VBI an upfront payment of $15 million, including an equity investment of approximately $3 million, contingent on achieving near-term milestones. VBI is also eligible to receive up to an additional $422 million in potential regulatory and commercial milestone payments and double-digit royalties in the licensed territories worldwide for VBI-2601 and APAC, excluding Japan, for PreHevbri. VBIV shares are down 28.50% at $1.73 during the premarket session on the last check Thursday.

Portfolio Pulse from Vandana Singh

July 06, 2023 | 11:38 am

FIS

FIS has entered an agreement for GTCR to acquire a majority stake in Worldpay at a valuation of $18.5 billion. FIS will retain 45% ownership in Worldpay, and GTCR has committed to invest up to $1.25 billion in additional growth capital to accelerate Worldpay's growth strategy.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 10:56 am

OBDC

Owl Rock Capital Corporation has been renamed to Blue Owl Capital Corporation and its ticker symbol on the New York Stock Exchange has changed to 'OBDC'. The company's equity and unsecured notes will continue to trade under the same CUSIPs and the business operations remain unchanged.

Portfolio Pulse from Charles Gross

July 06, 2023 | 10:40 am

APTV

B of A Securities analyst John Murphy has upgraded Aptiv (NYSE:APTV) from Neutral to Buy and raised the price target from $130 to $140.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 10:39 am

SG

B of A Securities analyst Sara Senatore has upgraded Sweetgreen (NYSE:SG) from Neutral to Buy and raised the price target from $9 to $17.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 10:36 am

ALLR

Allarity Therapeutics has priced its public offering of 2.44 million shares and warrants to purchase up to 2.44 million shares at a combined price of $4.50. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 10:14 am

ALLR

Allarity Therapeutics has priced its public offering of 2.44 million shares and common warrants to purchase up to 2.44 million shares at a combined price of $4.50, aiming to raise gross proceeds of approximately $11 million.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 10:02 am

AAPL

INTC

META

NVDA

The S&P 500 settled lower following the release of the U.S. Federal Reserve's recent meeting minutes. U.S. factory orders rose less than expected, and the Philadelphia SE Semiconductor Index fell, with Intel Corporation shares losing over 3%. Meta Platforms shares gained in anticipation of the launch of its Threads platform. The Nasdaq 100 slipped slightly, with minor declines in shares of Apple Inc and NVIDIA Corp. The CBOE Volatility Index rose 3.5%.

Portfolio Pulse from Lisa Levin

July 06, 2023 | 9:58 am

KRUS

LEVI

TRIB

VBIV

VMEO

Levi Strauss & Co., Vimeo, Inc., Kura Sushi USA, Inc., VBI Vaccines Inc., and Trinity Biotech plc are the stocks to watch heading into Thursday. Levi Strauss is expected to post quarterly earnings of 3 cents per share on revenue of $1.34 billion. Vimeo announced the departure of its CEO, Anjali Sud, and named Adam Gross as interim CEO. Kura Sushi is expected to have earned 13 cents per share on revenue of $49.57 million. VBI Vaccines announced the expansion of their hepatitis B partnership and a proposed public offering. Trinity Biotech is expected to report a quarterly loss of 6 cents per share on revenue of $18.50 million.

Portfolio Pulse from Lisa Levin

July 06, 2023 | 8:18 am

RACE

Ferrari N.V. (RACE) has announced a cash tender offer on its outstanding €650,000,000 1.500 per cent. Notes due 27 May 2025. The company is inviting eligible holders to tender their Notes for purchase by the company for cash up to an aggregate nominal amount of €175,000,000.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 7:47 am